Guardant Health, Inc.
$22.79B- Market cap
- $21.66B
- Debt
- +$1.50B
- Cash
- −$378.20M
Capital structure 94% equity / 6% debt · EV / Revenue 23.21x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: GH stock price vs KAR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KAR's multiple
Needs KAR P/S.
Implied fair value · at GH's multiple
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GH FY 2025 (ended Dec 31, 2025) · KAR FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 23.21x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
GUARDANT HEALTH, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
OPENLANE, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-15.14x
0.45x
Net debt / EBITDA
Leverage against operating earnings
-3.04x
0.97x
Cash and equivalents
Liquid reserves on the balance sheet
$378.20M
$141.50M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
GH vs NEO
Fulgent Genetics, Inc.
GH vs FLGT
EXACT SCIENCES CORP
GH vs EXAS
Natera, Inc.
GH vs NTRA
COPART INC
GH vs CPRT
CARMAX INC
GH vs KMX
LITHIA MOTORS INC
GH vs LAD
PENSKE AUTOMOTIVE GROUP, INC.
GH vs PAG
ASBURY AUTOMOTIVE GROUP INC
GH vs ABG
GROUP 1 AUTOMOTIVE INC
GH vs GPI
$1.50B
$555.50M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.